報價延遲最少15分鐘:2025/08/25 16:58 EDT
盤後時段
|
||||
|
35.31 
|
|
|
常規時段
|
|
|
|
|
||||||||||||
|
|
|
|
|
35.31
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-1.24/-0.12
|
|
企業價值
563.93M
|
| 資產負債 |
|
每股賬面淨值
7.79
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
126.08M
|
|
每股收益
9.13
|
|
同行比較
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
報價延遲最少15分鐘：2025/08/25 16:58 EDT
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| Surmodics Inc is a provider of performance coating technologies for intravascular medical devices and chemical and biological components for in vitro diagnostic (IVD) immunoassay tests and microarrays. The company's reportable segments are; Medical Device and In Vitro Diagnostics. Maximum revenue for the company is derived from its Medical Device segment which is involved in the manufacturing and licensing of performance coatings, including surface modification coating technologies and drug-delivery coating technologies. This segment also manufactures vascular intervention medical devices, including drug-coated balloons, mechanical thrombectomy devices, and radial access balloon catheters and guide sheaths. Geographically, the company derives key revenue from its domestic market. |
